Paper36746307
Recent advances in long-acting drug delivery systems for anticancer drug.
Pacheco C and 4 others. Adv Drug Deliv Rev, 2023. Cited by 113 papers, by iCite.
Cite this record
ConductScience Library. Recent advances in long-acting drug delivery systems for anticancer drug. Papers, record 36746307. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36746307
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Drug Delivery Systems | |
| Polymers |
Source PubMed
Cited by55
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 113 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42797500 | Therapeutic Resistance in Melanoma: Molecular Mechanisms and Emerging Pharmaceutical Strategies. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42797500 | PubMed |
| 42653458 | Thieno[3,2-d]pyrimidines in Anticancer Drug Discovery: Recent Advances in Drug Design and Molecular Targets. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653458 | PubMed |
| 42288537 | Development of surfactin-based nanocarrier for targeted doxorubicin delivery. | Sci Rep | 2026 | https://conductscience.org/library/papers/42288537 | PubMed |
| 42177586 | Transcriptional profiling and functional characterization of the Hc-NHR-49 gene in ivermectin resistance of Haemonchus contortus. | Parasit Vectors | 2026 | https://conductscience.org/library/papers/42177586 | PubMed |
| 42130845 | Biodegradable cross-linked flavone networks featuring either ester or carbamate linkages for controlled delivery of anti-cancer agents. | RSC Adv | 2026 | https://conductscience.org/library/papers/42130845 | PubMed |
| 41917675 | PEGylated Chitosan Nanoparticles: Engineering Multifunctional Platforms for Targeted Cervical and Lung Cancer Treatment. | Cancer Sci | 2026 | https://conductscience.org/library/papers/41917675 | PubMed |
| 41828829 | Electrospun Fibrous Architectures for Localized Delivery of Photosensitizers in Cancer Therapy. | Molecules | 2026 | https://conductscience.org/library/papers/41828829 | PubMed |
| 41767047 | ATP-sensitive peptide-based coacervates for intracellular delivery of therapeutic oligonucleotides. | Front Mol Biosci | 2026 | https://conductscience.org/library/papers/41767047 | PubMed |
| 41726439 | Machine Learning for Predicting Drug Release Behavior of PLGA Microspheres. | AMIA Annu Symp Proc | 2024 | https://conductscience.org/library/papers/41726439 | PubMed |
| 41634507 | Beyond the dose: a clearance-enabled in vitro platform for evaluating local therapies. | Drug Deliv Transl Res | 2026 | https://conductscience.org/library/papers/41634507 | PubMed |
| 41594677 | Magnetic Nanocarriers with ICPTES- and GPTMS-Functionalized Quaternary Chitosan for pH-Responsive Doxorubicin Release. | Biomolecules | 2026 | https://conductscience.org/library/papers/41594677 | PubMed |
| 41583445 | Covalent organic frameworks for cancer immunotherapy: mechanisms, applications, and prospects. | Front Immunol | 2025 | https://conductscience.org/library/papers/41583445 | PubMed |
| 41472401 | Peptomer Linkers Enable Kinetic Control over Co-Delivery of Multiple Chemotherapeutics. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/41472401 | PubMed |
| 41471080 | Development and Antitumor Evaluation of Doxorubicin-Loaded Two-Layered Sheets for Local Chemotherapy via Direct Drug Application to the Tumor Surface. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41471080 | PubMed |
| 41460317 | Design and characterization of phloretin-loaded PEG-lipid hybrid micelles for enhanced breast cancer therapy. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41460317 | PubMed |
| 41459545 | Marine-derived L-asparaginase: unlocking marine power in anti-tumor therapeutics. | Front Immunol | 2025 | https://conductscience.org/library/papers/41459545 | PubMed |
| 41426052 | Synthesis and anticancer potential of glycosides. | RSC Adv | 2025 | https://conductscience.org/library/papers/41426052 | PubMed |
| 41369447 | Therapeutic Potential of Nanoscale Metal-Organic Frameworks in Hepatocellular Carcinoma. | Nanomaterials (Basel) | 2025 | https://conductscience.org/library/papers/41369447 | PubMed |
| 41318792 | Dual-drug codelivery gelatin-based hydrogel of ARV-471 and Palbociclib enhances synergistic effect in breast cancer treatment. | Sci Rep | 2025 | https://conductscience.org/library/papers/41318792 | PubMed |
| 41301872 | Biomimetic Porous Coatings on a Biocompatible Ti-15Mo Alloy as a Platform for Local Delivery of Anticancer Drugs to Patient Tissues. | Biomedicines | 2025 | https://conductscience.org/library/papers/41301872 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36746307
GET https://conductscience.org/api/papers/v1/36746307/cited_by?page=2